Natalie Prinzi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Diabetes and cancer: glucose control impact on survival and tumor outcomes.
Journal: Reviews in endocrine & metabolic disorders
Published: February 13, 2026
Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma.
Journal: Future oncology (London, England)
Published: June 12, 2025
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behavior.
Journal: The journal of pathology. Clinical research
Published: October 08, 2024
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 02, 2024
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 29, 2024
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.
Journal: ESMO open
Published: December 21, 2023
An Italian real-world multicenter study of patients with advanced mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) of the gastro-entero-pancreatic system treated with chemotherapy.
Journal: Journal of endocrinological investigation
Published: December 11, 2023
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2.
Journal: Journal of hematology & oncology
Published: September 03, 2023
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.
Journal: Journal of endocrinological investigation
Published: July 14, 2023
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.
Journal: Virchows Archiv : an international journal of pathology
Published: June 08, 2023
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET).
Journal: Diagnostics (Basel, Switzerland)
Published: April 03, 2023
Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?
Journal: Critical reviews in oncology/hematology
Published: March 01, 2023
Last Updated: 09/26/2026